Prostaglandin E2 inhibits the release of tumor necrosis factor-α, rather than interleukin 1β, from human macrophages
- 31 January 1992
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 31 (1) , 85-90
- https://doi.org/10.1016/0165-2478(92)90015-g
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Endotoxin‐stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin‐1βin vitro during infectious peritonitisEuropean Journal of Clinical Investigation, 1990
- In vitro production of IL 1β, IL 1α, TNF and IL 2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulationEuropean Journal of Immunology, 1989
- Regulation of interleukin-1β and tumor necrosis factor secretion by the human monocytic leukemia cell line, THP-1Inflammation Research, 1989
- The pharmacologic regulation of interleukin-1 production: The role of prostaglandinsCellular Immunology, 1988
- Continuous Ambulatory Peritoneal DialysisNew England Journal of Medicine, 1988
- Regulation of thymocyte proliferative response by macrophage-derived prostaglandin E2 and inter leukin 1European Journal of Immunology, 1985
- Cyclic AMP levels and their regulation by prostaglandins in peritoneal macrophages of rats and humansInternational Journal of Immunopharmacology, 1984
- Immunomodulatory-antiinflammatory functions of E-type prostaglandins. Minireview with emphasis on macrophage-mediated effectsInternational Journal of Immunopharmacology, 1982
- Discontinuous density gradient separation of human minonuclear leucocytes using percoll® as gradient mediumJournal of Immunological Methods, 1979
- Prostaglandin E 1 Inhibits Platelet Aggregation by a Pathway Independent of Adenosine 3′,5′-MonophosphateScience, 1978